Literature DB >> 24225087

Hepatitis C and alcohol exacerbate liver injury by suppression of FOXO3.

Batbayar Tumurbaatar1, Irina Tikhanovich1, Zhuan Li1, Jinyu Ren1, Robert Ralston2, Sudhakiranmayi Kuravi1, Roosevelt Campbell1, Gaurav Chaturvedi3, Ting-Ting Huang4, Jie Zhao1, Junfang Hao5, Maura O'Neil6, Steven A Weinman7.   

Abstract

Hepatitis C virus (HCV) infection exacerbates alcoholic liver injury by mechanisms that include enhanced oxidative stress. The forkhead box transcription factor FOXO3 is an important component of the antioxidant stress response that can be altered by HCV. To test whether FOXO3 is protective for alcoholic liver injury, we fed alcohol to FOXO3(-/-) mice. After 3 weeks, one third of these mice developed severe hepatic steatosis, neutrophilic infiltration, and >10-fold alanine aminotransferase (ALT) elevations. In cell culture, either alcohol or HCV infection alone increased FOXO3 transcriptional activity and expression of target genes, but the combination of HCV and alcohol together caused loss of nuclear FOXO3 and decreased its transcriptional activity. This was accompanied by increased phosphorylation of FOXO3. Mice expressing HCV structural proteins on a background of reduced expression of superoxide dismutase 2 (SOD2; Sod2(+/-)) also had increased liver sensitivity to alcohol, with elevated ALT, steatosis, and lobular inflammation. Elevated ALT was associated with an alcohol-induced decrease in SOD2 and redistribution of FOXO3 to the cytosol. These results demonstrate that FOXO3 functions as a protective factor preventing alcoholic liver injury. The combination of HCV and alcohol, but not either condition alone, inactivates FOXO3, causing a decrease in expression of its target genes and an increase in liver injury. Modulation of the FOXO3 pathway is a potential therapeutic approach for HCV-alcohol-induced liver injury.
Copyright © 2013 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24225087      PMCID: PMC5745546          DOI: 10.1016/j.ajpath.2013.08.013

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  50 in total

1.  Hepatitis C virus core protein inhibits mitochondrial electron transport and increases reactive oxygen species (ROS) production.

Authors:  Masaaki Korenaga; Ting Wang; Yanchun Li; Lori A Showalter; Tehsheng Chan; Jiaren Sun; Steven A Weinman
Journal:  J Biol Chem       Date:  2005-09-08       Impact factor: 5.157

Review 2.  Role of different dietary fatty acids in the pathogenesis of experimental alcoholic liver disease.

Authors:  Amin A Nanji
Journal:  Alcohol       Date:  2004-08       Impact factor: 2.405

Review 3.  Stressing the role of FoxO proteins in lifespan and disease.

Authors:  Armando van der Horst; Boudewijn M T Burgering
Journal:  Nat Rev Mol Cell Biol       Date:  2007-06       Impact factor: 94.444

Review 4.  A brief introduction to FOXOlogy.

Authors:  B M Th Burgering
Journal:  Oncogene       Date:  2008-04-07       Impact factor: 9.867

Review 5.  Applications of post-translational modifications of FoxO family proteins in biological functions.

Authors:  Ying Zhao; Yachen Wang; Wei-Guo Zhu
Journal:  J Mol Cell Biol       Date:  2011-06-13       Impact factor: 6.216

6.  Cell culture and infection system for hepatitis C virus.

Authors:  Takanobu Kato; Tomoko Date; Asako Murayama; Kenichi Morikawa; Daisuke Akazawa; Takaji Wakita
Journal:  Nat Protoc       Date:  2006       Impact factor: 13.491

7.  Malnutrition impairs interferon signaling through mTOR and FoxO pathways in patients with chronic hepatitis C.

Authors:  Masao Honda; Kenji Takehana; Akito Sakai; Yusuke Tagata; Takayoshi Shirasaki; Shinobu Nishitani; Takahiko Muramatsu; Tatsuya Yamashita; Yasunari Nakamoto; Eishiro Mizukoshi; Yoshio Sakai; Taro Yamashita; Mikiko Nakamura; Tetsuro Shimakami; Minkyung Yi; Stanley M Lemon; Tetsuo Suzuki; Takaji Wakita; Shuichi Kaneko
Journal:  Gastroenterology       Date:  2011-03-31       Impact factor: 22.682

Review 8.  The cunning little vixen: Foxo and the cycle of life and death.

Authors:  Stephen M Hedrick
Journal:  Nat Immunol       Date:  2009-08-23       Impact factor: 25.606

9.  MicroRNA expression profile in Lieber-DeCarli diet-induced alcoholic and methionine choline deficient diet-induced nonalcoholic steatohepatitis models in mice.

Authors:  Angela Dolganiuc; Jan Petrasek; Karen Kodys; Donna Catalano; Pranoti Mandrekar; Arumugam Velayudham; Gyongyi Szabo
Journal:  Alcohol Clin Exp Res       Date:  2009-07-01       Impact factor: 3.455

Review 10.  The FoxO code.

Authors:  D R Calnan; A Brunet
Journal:  Oncogene       Date:  2008-04-07       Impact factor: 9.867

View more
  12 in total

1.  High-throughput sequencing reveals altered expression of hepatic microRNAs in nonalcoholic fatty liver disease-related fibrosis.

Authors:  Fatjon Leti; Ivana Malenica; Meera Doshi; Amanda Courtright; Kendall Van Keuren-Jensen; Christophe Legendre; Christopher D Still; Glenn S Gerhard; Johanna K DiStefano
Journal:  Transl Res       Date:  2015-05-04       Impact factor: 7.012

2.  Serine 574 phosphorylation alters transcriptional programming of FOXO3 by selectively enhancing apoptotic gene expression.

Authors:  Z Li; J Zhao; I Tikhanovich; S Kuravi; J Helzberg; K Dorko; B Roberts; S Kumer; S A Weinman
Journal:  Cell Death Differ       Date:  2015-10-16       Impact factor: 15.828

Review 3.  Alcoholic hepatitis and concomitant hepatitis C virus infection.

Authors:  Mohamed Shoreibah; Bhupinderjit S Anand; Ashwani K Singal
Journal:  World J Gastroenterol       Date:  2014-09-14       Impact factor: 5.742

Review 4.  New advances in molecular mechanisms and emerging therapeutic targets in alcoholic liver diseases.

Authors:  Jessica A Williams; Sharon Manley; Wen-Xing Ding
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

5.  Alcohol exposure differentially effects anti-tumor immunity in females by altering dendritic cell function.

Authors:  Matthew G Thompson; Flor Navarro; Lennox Chitsike; Luis Ramirez; Elizabeth J Kovacs; Stephanie K Watkins
Journal:  Alcohol       Date:  2016-10-18       Impact factor: 2.405

6.  Oncogenic signaling pathways and origins of tumor-initiating stem-like cells of hepatocellular carcinomas induced by hepatitis C virus, alcohol and/or obesity.

Authors:  Chia-Lin Chen; Hidekazu Tsukamoto; Keigo Machida
Journal:  Hepatol Int       Date:  2014-06-20       Impact factor: 6.047

7.  CYP2E1-dependent upregulation of SIRT7 is response to alcohol mediated metastasis in hepatocellular carcinoma.

Authors:  Chen Zhang; Jinqiu Zhao; Jie Zhao; Bohao Liu; Wenbin Tang; Yi Liu; Wenxiang Huang; Steven A Weinman; Zhuan Li
Journal:  Cancer Gene Ther       Date:  2022-07-28       Impact factor: 5.854

Review 8.  Pathogenesis of Alcoholic Liver Disease.

Authors:  Winston Dunn; Vijay H Shah
Journal:  Clin Liver Dis       Date:  2016-03-28       Impact factor: 6.126

9.  FoxO3 Modulates LPS-Activated Hepatic Inflammation in Turbot (Scophthalmus maximus L.).

Authors:  Mingzhu Pan; Jiahuan Liu; Dong Huang; Yanlin Guo; Kai Luo; Mengxi Yang; Weihua Gao; Qiaoqing Xu; Wenbing Zhang; Kangsen Mai
Journal:  Front Immunol       Date:  2021-07-01       Impact factor: 7.561

Review 10.  Role of farnesoid X receptor and bile acids in alcoholic liver disease.

Authors:  Sharon Manley; Wenxing Ding
Journal:  Acta Pharm Sin B       Date:  2015-03-09       Impact factor: 11.413

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.